PAR Genes: Molecular Probes to Pathological Assessment in Breast Cancer Progression
2011

PAR Genes: Molecular Probes for Breast Cancer

publication Evidence: moderate

Author Information

Author(s): Uziely Beatrice, Turm Hagit, Maoz Myriam, Cohen Irit, Maly Bella, Bar-Shavit Rachel

Primary Institution: Hadassah-University Hospital

Hypothesis

Can PAR1 and PAR2 serve as molecular probes for breast cancer diagnosis and therapy?

Conclusion

PAR1 and PAR2 may be used as indicators of breast cancer progression and targets for treatment.

Supporting Evidence

  • PAR1 and PAR2 levels in body fluids can reflect cancer progression.
  • High expression of PAR1 is linked to aggressive tumor behavior.
  • PAR1 signaling is crucial for breast cancer cell invasion and metastasis.

Takeaway

Scientists are studying special proteins called PAR1 and PAR2 to help doctors understand and treat breast cancer better.

Methodology

The study involved examining the role of PAR1 and PAR2 in breast cancer using various experimental models, including xenograft mice.

Limitations

The study does not provide information on the half-life of released peptides or the relative contribution of PAR1 versus PAR2.

Digital Object Identifier (DOI)

10.4061/2011/178265

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication